Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine.

Crooke, Stephen N; Ovsyannikova, Inna G; Kennedy, Richard B; Warner, Nathaniel D; Poland, Gregory A

Crooke, Stephen N; Ovsyannikova, Inna G; Kennedy, Richard B; Warner, Nathaniel D; Poland, Gregory A.

Affiliation

Crooke SN; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
Ovsyannikova IG; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
Kennedy RB; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA.
Warner ND; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Poland GA; Mayo Clinic Vaccine Research Group, Mayo Clinic, Rochester, MN, USA. Electronic address: poland.gregory@mayo.edu.

Vaccine ; 38(50): 7897-7904, 2020 11 25.

Article in En | MEDLINE | ID: mdl-33158591

Subject(s)

Immunity, Cellular; Immunity, Humoral; Measles-Mumps-Rubella Vaccine/administration & dosage; Measles-Mumps-Rubella Vaccine/immunology; Rubella/immunology; Adult; Chemokines/immunology; Chemokines/metabolism; Cytokines/immunology; Cytokines/metabolism; Female; Humans; Immunization Schedule; Leukocytes, Mononuclear/immunology; Leukocytes, Mononuclear/metabolism; Middle Aged; Rubella/prevention & control; Young Adult

Key words

Chemokine; Cytokine; Immunity, Cellular; Immunity, Humoral; Immunity, Innate; MMR; Measles-mumps-rubella; Rubella

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rubella / Measles-Mumps-Rubella Vaccine / Immunity, Humoral / Immunity, Cellular Type of study: Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: Vaccine Year: 2020 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google